ATI RN
Immune System Medication Questions
Question 1 of 5
The nurse teaches the female patient receiving immune modulating drugs about the need to use barrier contraceptives. The patient says, I hate using barrier contraceptives. Why can't I just take oral contraceptives? What is the nurse's best response?
Correct Answer: A
Rationale: The correct answer is A because immune modulating drugs can affect liver enzymes, potentially altering the metabolism of oral contraceptives. This can lead to decreased effectiveness or increased side effects of oral contraceptives. Choice B is incorrect because oral contraceptives do not increase the action of immune modulating drugs, so dosage adjustments are not necessary. Choice C is incorrect because immune modulators do not directly make oral contraceptives ineffective due to hormonal impacts. Choice D is incorrect because high-estrogen pills are not the only option if barrier contraceptives are not preferred; rather, a different form of contraception should be discussed based on individual needs.
Question 2 of 5
A recent laboratory results indicated an “undetectable†human immunodeficiency virus viral load. What is the nurse's best response?
Correct Answer: D
Rationale: The correct answer is D. The nurse should educate the patient about the continued need for medications and ongoing monitoring because an undetectable viral load does not mean the medication stopped working. It indicates treatment success but does not signify a cure. The patient still needs to adhere to the medication regimen to maintain the viral load suppression and prevent resistance. Rescheduling the clinic visit (B) or immediate action (A) is not necessary based solely on this result. Simply congratulating the patient (C) without providing further information on the importance of medication adherence and monitoring would be inadequate. Therefore, choice D is the best response to ensure the patient understands the significance of continuing treatment.
Question 3 of 5
All transplant drugs have the same advisory, to use caution when administering them with another immunosuppressant drug because of the increased risk for:
Correct Answer: D
Rationale: The correct answer is D: Infection. When transplant drugs are administered with another immunosuppressant, the immune system is further suppressed, increasing the risk of infections. This is because the body's ability to fight off harmful pathogens is compromised. Nausea and vomiting (A), edema (B), and anemia (C) are not directly related to the interaction of transplant drugs with other immunosuppressants. Infection is the most critical concern due to the weakened immune response.
Question 4 of 5
Your patient is receiving basiliximab and develops cytokine release syndrome. You would expect to see:
Correct Answer: B
Rationale: Basiliximab is a monoclonal antibody that can cause cytokine release syndrome, characterized by flu-like symptoms such as chills. This occurs due to the rapid release of cytokines in response to the antibody, leading to systemic inflammatory response. Coughing, tremors, and weakness are not typically associated with cytokine release syndrome. Therefore, the correct answer is B (Chills).
Question 5 of 5
The father of a 4-month-old infant calls in to the clinic reporting that his child is having a reaction to immunizations. What is the most important piece of information the nurse should elicit?
Correct Answer: C
Rationale: The correct answer is C: The signs and symptoms the infant is experiencing. This is important because it helps determine the severity of the reaction and guide appropriate interventions. Understanding the specific symptoms can aid in differentiating between a mild versus severe reaction. Options A, B, and D are not as critical because knowing the exact time of immunization, administering acetaminophen, or the sites of administration do not provide immediate information on the infant's current condition and necessary actions.